FindTrial
Sign In

study for comparison of dexmedetomidine and clonidine infusion in patients undergoing laparoscopic surgeries

A randomised control study for comparison of dexmedetomidine and clonidine infusion on hemodynamic stability in patients undergoing laparoscopic surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/017987
Enrollment
52
Registered
2019-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: K80-K87- Disorders of gallbladder, biliary tract and pancreas

Interventions

Intervention1: Dexmedetomidine: 0.3mcg/kg/hr infusion started 15 minutes before induction of anaesthesia till the release of pneumoperitoneum Intervention2: Clonidine: 2mcg/kg/hr infusion started 15 m

Sponsors

Rahul SS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing laparoscopic surgeries

Exclusion criteria

Exclusion criteria: patient refusal ASA III and above known hepatic and renal dysfunction known cardiac arrhythmias, congenital heart diseases pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
Comparison of hemodynamic parameters during surgery using the two pharmacological agentsTimepoint: Comparison of hemodynamic parameters during surgery using the two pharmacological agents—

Secondary

MeasureTime frame
Study of postoperative analgesia , incidence of nausea and vomiting and post operative analgesia requirement in two groupsTimepoint: Study of postoperative analgesia , incidence of nausea and vomiting and post operative analgesia requirement in two groups—

Countries

India

Contacts

Public ContactRahul S S

Shri Sathya Sai Medical College and Research Institute

esenkeyem@gmail.com9786743120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026